Drug combinations: From laboratory to practice

Journal of Laboratory and Clinical Medicine

Volumn 132, Issue 1, 1998, Pages 6-8

  Chou, T C ^a  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032125835     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2143(98)90018-X     Document Type: Editorial

References (20)

1. T-C Chou P Talalay Analysis of combined drug effects: a new look at a very old problem Trends Pharmacol Sci 4 1983 450 454
2. T-C Chou The median-effect principle and the combination index for quantitation of synergism and antagonism T-C Chou D Rideout Synergism and antagonism in chemotherapy 1991 Academic Press San Diego 61 102
3. T-C Chou D Rideout JH Chou JR Bertino Chemotherapeutic synergism, potentiation and antagonism 2nd ed. R Dulbecco Encyclopedia of human biology vol 2 1997 Academic Press San Diego 675 683
4. T-C Chou RJ Motzer Y Tong GJ Bosl Computerized quantitation of synergism and antagonism of taxol, topotecan and cisplatin against teratocarcinoma cell growth: a rational approach to clinical protocol design J Natl Cancer Inst 86 1994 1517 1524
5. JR Bertino T-C Chou Chemotherapy: synergism and antagonism 2nd ed JR Bertino Encyclopedia of cancer vol 1 1997 Academic Press San Diego 368 379
6. J Guo MM Reidenberg Inhibition of 11-β hydroxysteroid dehydrogenase by bioflavonoids and their interaction with furosemide and gossypol J Lab Clin Med 131 1998 32 38
7. Permuterm Subject Index, Science Citation Index 1997 Institute for Scientific Information Philadelphia
8. A Goldin N Mantel The employment of combinations of drugs in the chemotherapy of neoplasia: a review Cancer Res 17 1957 635 654
9. MC Berenbaum What is synergy? Pharmacol Rev 41 1989 93 141
10. T-C Chou P Talalay Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors Adv Enzyme Regul 22 1984 27 55
11. T-C Chou Relationships between inhibition constants and fractional inhibitions in enzyme-catalyzed reactions with different numbers of reactants, different reaction mechanisms, and different types of mechanisms of inhibition Mol Pharmacol 10 1974 235 247
12. T-C Chou Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands J Theor Biol 39 1996 253 276
13. T-C Chou P Talalay Generalized equations for the analysis of inhibitors of Michaelis-Menten and higher order kinetic systems with two or more mutually exclusive and nonexclusive inhibitors Eur J Biochem 115 1981 207 216
14. T-C Chou P Talalay Applications of the median-effect principle for the assessment of low-dose risk of carcinogens and for the quantitation of synergism and antagonism of chemotherapeutic agents KR Harrap TA Connors New Avenues of developmental cancer chemotherapy 2nd ed Bristol-Myers Symposium series 1987 Academic Press New York 37 64
15. 50, synergism, antagonism, low-dose risk, receptor-ligand binding and enzyme kinetics Manual and software 1987 Biosoft Cambridge, England
16. T-C Chou M Hayball CalcuSyn for Windows, multiple-drug dose-effect analyzer and manual 1996 Biosoft Cambridge, England
17. S Loewe Antagonism and antagonist Pharmacol Rev 9 1957 237 242
18. MC Berenbaum Synergy, additivism and antagonism in immunosupression: a critical review Clin Exp Immunol 28 1977 1 18
19. JL Webb 2nd ed Enzyme metabolic inhibitors vol 1 1963 Academic Press New York 55 79
20. Science Citation Index 1998 Institute for Scientific Information Philadelphia 1983–1998